These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19665733

  • 1. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
    Butt MU, Sailhamer EA, Li Y, Liu B, Shuja F, Velmahos GC, DeMoya M, King DR, Alam HB.
    J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
    [Abstract] [Full Text] [Related]

  • 2. Cell protective mechanism of valproic acid in lethal hemorrhagic shock.
    Li Y, Liu B, Sailhamer EA, Yuan Z, Shults C, Velmahos GC, deMoya M, Shuja F, Butt MU, Alam HB.
    Surgery; 2008 Aug; 144(2):217-24. PubMed ID: 18656628
    [Abstract] [Full Text] [Related]

  • 3. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
    Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E.
    J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells.
    Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, Velmahos GC, de Moya M, Alam HB.
    Resuscitation; 2011 Jan; 82(1):105-9. PubMed ID: 21036453
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
    Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, Liu B, Rhee P, Kirkpatrick J, Alam HB.
    Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255
    [Abstract] [Full Text] [Related]

  • 6. Surviving blood loss without fluid resuscitation.
    Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, Shuja F, Demoya M, Velmahos G, Alam HB.
    J Trauma; 2008 Mar; 64(3):629-38; discussion 638-40. PubMed ID: 18332802
    [Abstract] [Full Text] [Related]

  • 7. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.
    Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, Demoya M, Alam HB.
    J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049
    [Abstract] [Full Text] [Related]

  • 8. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
    Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, Kim JM, Park DK, Kun Lee S, Kim M, Roh JK.
    Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
    [Abstract] [Full Text] [Related]

  • 9. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
    Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J.
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
    [Abstract] [Full Text] [Related]

  • 10. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
    Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM.
    J Neurochem; 2004 Jun; 89(6):1358-67. PubMed ID: 15189338
    [Abstract] [Full Text] [Related]

  • 11. JNK mediates hepatic ischemia reperfusion injury.
    Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA.
    J Hepatol; 2005 Jun; 42(6):850-9. PubMed ID: 15885356
    [Abstract] [Full Text] [Related]

  • 12. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
    Kanai H, Sawa A, Chen RW, Leeds P, Chuang DM.
    Pharmacogenomics J; 2004 Jun; 4(5):336-44. PubMed ID: 15289798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage.
    Alam HB, Hashmi S, Finkelstein RA, Shuja F, Fukudome EY, Li Y, Liu B, Demoya M, Velmahos GC.
    J Trauma; 2010 May; 68(5):1084-98. PubMed ID: 20453763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA.
    Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.
    Kochanek AR, Fukudome EY, Li Y, Smith EJ, Liu B, Velmahos GC, deMoya M, King D, Alam HB.
    J Surg Res; 2012 Jul 01; 176(1):185-94. PubMed ID: 21816439
    [Abstract] [Full Text] [Related]

  • 19. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L, Gillet N, Stamatopoulos B, Delforge A, Dejeneffe M, Massy M, Meuleman N, Kentos A, Martiat P, Willems L, Bron D.
    Exp Hematol; 2007 Oct 01; 35(10):1527-37. PubMed ID: 17697742
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.
    Li Y, Liu B, Dillon ST, Fukudome EY, Kheirbek T, Sailhamer EA, Velmahos G, deMoya M, Libermann TA, Alam HB.
    J Surg Res; 2010 Mar 01; 159(1):474-81. PubMed ID: 19765733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.